Suchergebnisse - "Saif, Muhammad Wasif"

PubPharm (580)

31

Hepatectomy for Breast Cancer Metastasis and Sarcoma are more likely to have Adverse Outcomes than Hepatectomy for Primary Hepatocellular Cancer or for Colorectal Metastasis

enthalten in: Cancer medicine journal | 2020

von Aziz, H. | Hanna, K. | Saif, M. | +3

32

Gastrointestinal Stromal Tumors Incidentalomas : A Case Series

enthalten in: Cancer medicine journal | 2020

von Ferig, M. | Alarcon Velasco, S. | Van Doren, L. | +1

33

Is There any Survival Benefit of Maintenance Chemotherapy Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer Patients with Post-Surgery Elevated CA 19-9?

enthalten in: JOP : Journal of the pancreas | 2020

von Saif, M. | Smith, M. | Goodman, M. | +1

34

New Developments in the Treatment of Pancreatic Cancer : Highlights from the 44th ASCO Annual Virtual Meeting, May 29-31, 2020

enthalten in: JOP : Journal of the pancreas | 2020

von Saif, M.

35

Treatment options in BRAF-mutant metastatic colorectal cancer

enthalten in: Anti-cancer drugs | 2020

von Bernabe-Ramirez, C. | Patel, R. | Chahal, J. | +1

36

COVID-19 Clinical Research

enthalten in: Journal of cellular signaling | 2020

von Chi, J. | Chitty, D. | Lee, M. | +5

37

Challenges to Treat Cancer Patients During COVID-19 Pandemic

enthalten in: Annals of King Edward Medical University | 2020

von Saif, M.

38

Sunitinib as Successful Maintenance Therapy for Recurrent Pancreatic Serous Cystadenocarcinoma

enthalten in: American journal of therapeutics | 2020

von Inayat, F. | Aleem, S. | Saif, M.

39

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT) : a multicentre, open-label phase 2 study

enthalten in: The lancet. Gastroenterology & hepatology | 2020

von Philip, P. | Lacy, J. | Portales, F. | +18

CommentIn: Lancet Gastroenterol Hepatol. 2020 Mar;5(3):234-236. - PMID 31953078

40

Chronic Use of Long-Acting Somatostatin Analogues (SSAs) and Exocrine Pancreatic Insufficiency (EPI) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) : An Under-recognized Adverse Effect

enthalten in: Cancer medicine journal | 2020

von Saif, M. | Romano, A. | Smith, M. | +2